STATES OF JERSEY
HEALTH AND SOCIAL SERVICES DEPARTMENT
Medicines (Jersey) Law 1995 - Administration and Supply of Medicines under Patient Group Direction
- Introduction
A Patient Group Direction (PGD) is a written instruction which authorises defined health professionals to supply and/or administer a medicine without the need for a prescription to be written by a doctor. It is not a form of prescribing and there is no specific training that health professionals must undertake before supplying or administering medicines in this way unless so specified in the PGD.
The Medicines (Health Professional - Exemption) (Jersey) Order 2001 allows a relevant health professional to supply and/or administer a medicinal product in accordance with a direction given by the Minister. A correctly formatted PGD will satisfy the requirements of this Order in that it specifies the amount of a medicine which may be administered or supplied, the circumstances in which it can be administered or supplied, and the records which must be maintained.
- Proposals
The Minister is advised that nine PGDs have been drawn up by senior medical and pharmacy staff and that they have been duly approved by the Health and Social Services Drugs and Therapeutics Committee as being appropriate and also compliant with the requirements of the Medicines (Health Professional - Exemption) (Jersey) Order 2001.
The PGDs to which this report applies are:
PGD 017 Administration of Flumazenil Injection
PGD 018 Administration of Midazolam Injection
PGD 019 Administration of Lidocaine Oral Spray
PGD 020 Administration of Measles, Mumps & Rubella (MMR) Vaccine
PGD 021 Administration of standard dose Diphtheria, Tetanus, Acellular Pertussis, Inactivated Polio & Haemophillus Influenzae Type B Vaccine
PGD 022 Administration of Meningococcal Group C Conjugate Vaccine
PGD 023 Administration of Haemophilus Influenzae Type B & Meningococcal Conjugate Vaccine (Hib-MenC)
PGD 024 Administration of Pneumococcal Conjugate Vaccine (Prevenar)
PGD 025 Administration of low dose Diphtheria, Tetanus, Acellular Pertussis and Inactivated Polio Vaccine (dTaP/IPV - Repevax)
- Recommendations
The Minister is requested to note the above PGDs and to give a direction that the medicinal products specified in the PGDs may be administered in accordance with the requirements of the Patient Group Directions.
Paul McCabe
Chief Pharmacist
3rd July 2007